Mepolizumab in Hypereosinophilic Syndrome: A Systematic Review and Meta-analysis

We aimed to evaluate the efficacy and safety of mepolizumab (MEP) in the management of hypereosinophilic syndrome (HES). A systematic search was performed, and articles published until March 2021 were analyzed. The primary efficacy results evaluated were hospitalization rate related to HES, morbidit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, José Mario, Prota, Francisco Eduardo, Villagelin, Danilo, Bley, Fernanda, Bernardo, Wanderley Marques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478134/
https://www.ncbi.nlm.nih.gov/pubmed/34644737
http://dx.doi.org/10.6061/clinics/2021/e3271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478134/
https://www.ncbi.nlm.nih.gov/pubmed/34644737
http://dx.doi.org/10.6061/clinics/2021/e3271

Ejemplares similares